Peptide legal status
How each of the 28 peptides on peptidefix is regulated in the United Kingdom, the United States and Australia, as understood on the date shown. Verify with the regulator: MHRA (UK), FDA (US), TGA (AU).
5-amino-1MQ
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
BPC-157
UKNot an approved medicine.
USNot an approved medicine.
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-22
Cagrilintide
UKNot an approved medicine. Investigational.
USNot an approved medicine. Investigational.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
CJC-1295
UKNot an approved medicine.
USNot an approved medicine.
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-22
Epitalon
UKNot an approved medicine. The MHRA products register returns no result for epitalon (checked 2026-09-22).
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
FOXO4-DRI
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
GHK-Cu
UKNot an approved medicine. Used as a cosmetic ingredient.
USNot an approved medicine. Used as a cosmetic ingredient.
AUNot listed by name in the Poisons Standard (June 2026). Schedule 4 covers copper compounds for human use, but with exceptions for preparations below stated copper limits, so whether a particular GHK-Cu preparation falls under it depends on the product.
Checked 2026-09-22
Glutathione
UKNot an approved medicine.
USNot an approved medicine.
AUPrescription only when for injection or infusion. The Poisons Standard (June 2026) lists glutathione for parenteral use in Schedule 4; oral forms are sold as supplements.
Checked 2026-09-22
Ipamorelin
UKNot an approved medicine. The MHRA products register returns no result for ipamorelin (checked 2026-09-22).
USNot an approved medicine. The openFDA drug label database holds no current label for ipamorelin (checked 2026-09-22).
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-22
KPV
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
MOTS-c
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
NAD+
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Pancragen
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Pinealon
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
PT-141
UKNot an approved medicine. The MHRA products register returns no result for bremelanotide or Vyleesi (checked 2026-09-22).
USApproved medicine. The FDA label for Vyleesi states it is indicated for the treatment of premenopausal women with acquired, generalised hypoactive sexual desire disorder that is not due to a co-existing medical or psychiatric condition, relationship problems, or the effects of a medication or drug substance.
AUNot an approved medicine. Bremelanotide is not listed by name in the Poisons Standard (June 2026); melanotan II, a related melanocortin peptide, is Schedule 4. No ARTG registration was found.
Checked 2026-09-22
Retatrutide
UKNot an approved medicine. Investigational.
USNot an approved medicine. Investigational. Eli Lilly plans to apply to the FDA in the first quarter of 2027 (Lilly results release, August 2026).
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-25
Selank
UKNot an approved medicine. The MHRA products register returns no result for selank (checked 2026-09-22).
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Semaglutide
UKApproved medicine. Semaglutide products hold UK marketing authorisations and appear on the MHRA products register (checked 2026-09-22).
USApproved medicine. The FDA label for Ozempic states it is indicated alongside diet and exercise to improve glycaemic control in adults with type 2 diabetes and to reduce cardiovascular risk in defined groups; Rybelsus is the oral tablet form. Separate labels cover weight management.
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-26
Semax
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Sermorelin
UKNot an approved medicine. The MHRA products register returns no result for sermorelin (checked 2026-09-22).
USNo current FDA label. The openFDA drug label database holds no current label for sermorelin (checked 2026-09-22).
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-22
SLU-PP-332
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
SS-31 (elamipretide)
UKNot an approved medicine.
USApproved medicine (accelerated approval, 19 September 2025) as Forzinity for Barth syndrome in adults and children weighing at least 30 kg. Not approved for any other use.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
TB-500
UKNot an approved medicine.
USNot an approved medicine.
AUPrescription only. Thymosin beta 4 is listed in Schedule 4 of the Poisons Standard (June 2026), and TB-500 is a fragment of thymosin beta 4.
Checked 2026-09-22
Tesamorelin
UKNot an approved medicine. The MHRA products register returns no result for tesamorelin or Egrifta (checked 2026-09-22), and the EU marketing-authorisation application for Egrifta was withdrawn by the company.
USApproved medicine. The FDA label for Egrifta SV states it is indicated for the reduction of excess abdominal fat in adults with HIV and lipodystrophy, and that it is not indicated for weight-loss management. Long-term cardiovascular safety is stated on the label as not established.
AUPrescription only. Tesamorelin is not listed by name in the Poisons Standard (June 2026), but Schedule 4 lists growth hormone releasing hormones (GHRHs) as a class, and tesamorelin is a GHRH analogue. No ARTG registration was found.
Checked 2026-09-22
Thymogen
UKNot an approved medicine.
USNot an approved medicine.
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Thymosin alpha-1
UKNot an approved medicine. The MHRA products register returns no result for thymalfasin (checked 2026-09-22).
USNot an approved medicine. The openFDA drug label database holds no current label for thymalfasin (checked 2026-09-22).
AUNot an approved medicine. Not listed by name in the Poisons Standard (June 2026).
Checked 2026-09-22
Tirzepatide
UKApproved medicine. Mounjaro (tirzepatide) holds a Great Britain marketing authorisation, PLGB 14895/0343, listed on the MHRA products register (checked 2026-09-22).
USApproved medicine. The FDA label for Mounjaro states it is indicated alongside diet and exercise to improve glycaemic control in adults and children aged 10 and over with type 2 diabetes. A separate label, Zepbound, covers reducing and maintaining weight reduction in adults with obesity, or overweight with a weight-related condition, and treating moderate to severe obstructive sleep apnoea in adults with obesity.
AUPrescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-26
VIP (vasoactive intestinal peptide)
UKApproved medicine: aviptadil with phentolamine (Invicorp), intracavernosal injection for erectile dysfunction, licensed since 2000. Not approved for any other use.
USNot an approved medicine.
AUPrescription only. Aviptadil, the synthetic form, is listed in Schedule 4 of the Poisons Standard (June 2026).
Checked 2026-09-22